Toggle navigation
Home
Search
Services
Blog
Contact
About
Early Therapeutics Development with Phase 2 Emphasis-261017105
Sloan Kettering Institute
Search grants from Sloan Kettering Institute
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
SUDDEN DEATH IN YOUNG ? (SDY) ?IDDA Program Overhead (POH) -Overhead Cost
Competitive Renewal for Multicenter Uveitis Steroid Treatment (MUST) Trial
Influenza Preparedness in the Americas Region
Molecular Recognition of Metal Ions by the Merr Protein
Post Coronary Artery Bypass Graft Study
Recently added grants:
Representation of Familiar Images in Ventral Stream Visual Cortex
Transcriptional regulators of iris muscle cell development
OCT in the Ocular Hypertension Treatment Study: 20 Year Follow-up
Iron and Diabetic Retinopathy
Roles for Mismatch Repair Proteins in Maintaining Genome Stability
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA017105-010
Application #
7191423
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2005
Total Cost
Indirect Cost
Institution
Name
Sloan Kettering Institute
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2005
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017105
/ Sloan Kettering Institute
NIH 2004
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017105
/ Sloan Kettering Institute
NIH 2003
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017105
/ Sloan Kettering Institute
NIH 2002
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017105
/ Sloan Kettering Institute
Comments
Be the first to comment on this grant